Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Flurbiprofen Sodium 0.03% Drops 2.5 Ml By Actavis Pharma

Image 0 of Flurbiprofen Sodium 0.03% Drops 2.5 Ml By Actavis PharmaImage 1 of Flurbiprofen Sodium 0.03% Drops 2.5 Ml By Actavis Pharma

Flurbiprofen Sodium 0.03% Drops 2.5 Ml By Actavis Pharma

Call for Price

Flurbiprofen Sodium 0.03% Drops 2.5 Ml By Actavis Pharma This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD2617942/RXB10050180/RXA610134Size : 2.5 ML
Selling UoM : EA
NDC: 60758-0910-03
UPC Barcode :360758910038
Supplier: 0050000679 ACTAVIS PHARMA INC/GENERIC
Supplier Material : 091003
Generic Code : 007905 FLURBIPROFEN SODIUM OPHTHALMIC DROPS 0.0
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product

Have a question?

  Call for Price

Product Description.:

Drops , clear , clear

OCUFEN? (flurbiprofen sodium ophthalmic solution, USP) 0.03% is a sterile topical nonsteroidal anti-inflammatory product for ophthalmic use.

Contains: Active: flurbiprofen sodium 0.03% (0.3 mg/mL). Preservative: thimerosal 0.005%. Inactives: citric acid edetate disodium polyvinyl alcohol 1.4% potassium chloride purified water sodium chloride and sodium citrate. May also contain hydrochloric acid and/or sodium hydroxide to adjust the pH. The pH of OCUFEN? ophthalmic solution is 6.0 to 7.0. It has an osmolality of 260-330 mOsm/kg.

INDICATIONS

OCUFEN? ophthalmic solution is indicated for the inhibition of intraoperative miosis.
DOSAGE AND ADMINISTRATION

A total of four (4) drops of OCUFEN? ophthalmic solution should be administered by instilling one (1) drop approximately every 1/2 hour beginning 2 hours before surgery.

SIDE EFFECTS

Transient burning and stinging upon instillation and other minor symptoms of ocular irritation have been reported with the use of OCUFEN? ophthalmic solution. Other adverse reactions reported with the use of OCUFEN? ophthalmic solution include: fibrosis, miosis, and mydriasis.

Increased bleeding tendency of ocular tissues in conjunction with ocular surgery has also been reported.

DRUG INTERACTIONS

Interaction of OCUFEN? ophthalmic solution with other topical ophthalmic medications has not been fully investigated.

Although clinical studies with acetylcholine chloride and animal studies with acetylcholine chloride or carbachol revealed no interference, and there is no known pharmacological basis for an interaction, there have been reports that acetylcholine chloride and carbachol have been ineffective when used in patients treated with OCUFEN? ophthalmic solution.